Cyanocobalamin IM at 500–1,000 µg is the high-dose injectable form of vitamin B12 commonly used when oral absorption is compromised. Clinicians prescribe it to maintain or restore B12 status in pernicious anemia, malabsorption syndromes, and other causes of deficiency. The IM route bypasses intestinal absorption, making it suitable for patients who cannot take or absorb oral B12. It is distinct from over-the-counter oral supplements and from the intranasal product Nascobal.
This review synthesizes prescribing and patient-safety information from established clinical references including WebMD, MedlinePlus, the Mayo Clinic, RxList, Drugs.com, and the NHS entry on cyanocobalamin. Conclusions are limited to the facts and side-effect profiles reported in those sources rather than primary pharmacokinetic trials or unpublished data.
High-dose cyanocobalamin IM performs well for rapidly repleting or maintaining B12 in people with documented deficiency because it delivers 500–1,000 µg per dose versus a 2.4 µg recommended daily intake for most adults. The best features are its ability to bypass gut absorption and its clear indication in pernicious anemia; the worst are predictable injection-site reactions, systemic side effects such as headache or nausea, allergy risk from the cobalt component, and an explicit warning about optic nerve harm in people with Leber's hereditary optic neuropathy.
When is high-dose cyanocobalamin IM indicated?
Cyanocobalamin IM is indicated to treat and prevent vitamin B12 deficiency arising from pernicious anemia, stomach or bowel disorders, surgical resection, or any condition that impairs intestinal absorption. MedlinePlus and the Mayo Clinic note the injection is used when oral absorption is inadequate and can also be used diagnostically (for example, in historical Schilling testing contexts).
WebMD emphasizes that in countries like the U.S. most people obtain enough B12 from diet (2.4 µg/day for most adults), so the IM formulation is targeted at patients with malabsorption, strict vegans who cannot maintain levels by diet alone, or those with documented deficiency.
Does 500–1,000 µg IM deliver meaningful clinical repletion?
The product provides 500–1,000 µg of cyanocobalamin per intramuscular dose—many clinical protocols use large single doses because they far exceed the 2.4 µg daily recommended intake and reliably increase circulating B12 when delivered parenterally. Sources in this brief describe the IM route as effective specifically because it bypasses intestinal absorption.
Efficacy for preventing anemia and neurologic progression in deficiency is well established in standard clinical references; the injection is a recognized therapy for preventing permanent nerve damage associated with prolonged deficiency.
What adverse effects and contraindications should clinicians watch for?
Common adverse effects reported across references include injection-site reactions (pain, redness, swelling), gastrointestinal symptoms (nausea, diarrhea, upset stomach), and systemic complaints such as headache and feeling weak or tired. RxList and WebMD list these as commonly observed reactions.
There are specific safety cautions: Drugs.com flags a risk of optic nerve damage (possible blindness) in people with Leber's hereditary optic neuropathy. The NHS notes cobalt-containing products can provoke sensitivity reactions in people allergic to cobalt, with symptoms that can start immediately or up to 3 days after exposure. Mayo Clinic states the injection should be given only by or under direct medical supervision.
How is the injection given and what monitoring is required?
The IM injection must be administered intramuscularly by a clinician or under direct supervision, per the Mayo Clinic entry. Because it bypasses the gut, it is the route of choice when intestinal absorption is impaired. MedlinePlus emphasizes that it is used when oral therapy is not feasible.
Clinicians should monitor hematologic response and neurologic signs after initiation and be alert for allergic reactions and injection-site complications. The reviewed sources advise that use and follow-up be handled in a clinical setting rather than self-administration without professional oversight.
How does this compare to other B12 options in practice?
WebMD notes cyanocobalamin is available in multiple forms: OTC oral supplements, prescription intranasal spray (Nascobal), and injectable products like Cyanoject. The IM high-dose option is chosen primarily for malabsorption and pernicious anemia; nasal or oral routes may suffice when absorption is intact.
Because injections require clinic visits or trained administration, convenience and access are practical limitations. The safety profile—particularly the Leber's disease warning and cobalt allergy potential—means some patients will be directed to alternative formulations when appropriate.
Pros & Cons
- ✅ Delivers 500–1,000 µg per IM dose, far exceeding the typical adult RDI of 2.4 µg and reliably repleting stores when absorption is impaired
- ✅ Bypasses intestinal absorption, making it suitable for pernicious anemia and other malabsorption states (MedlinePlus, Mayo Clinic)
- ✅ Appropriate for diagnostic contexts historically linked to B12 absorption testing (Schilling test referenced in WebMD)
- ✅ Available as a prescription option distinct from OTC oral B12 and intranasal alternatives, allowing clinicians to tailor route to patient needs
- ✅ Well established in clinical references for preventing anemia and nerve damage from prolonged deficiency
- ❌ Injection-site reactions (pain, redness, swelling) and systemic side effects such as headache, nausea, diarrhea, and weakness are commonly reported (RxList, WebMD)
- ❌ Contains cobalt and can cause hypersensitivity in people allergic to cobalt; reactions can begin immediately or up to 3 days later (NHS)
- ❌ Explicit warning for people with Leber's hereditary optic neuropathy due to risk of optic nerve damage and possible blindness (Drugs.com)
- ❌ Requires administration by or under the supervision of a healthcare professional, limiting convenience (Mayo Clinic)
- ❌ Not suitable as first-line if oral absorption is intact — oral or intranasal options may be preferable in those cases (WebMD)
How It Compares to the Competition
- Nascobal (cyanocobalamin nasal spray) — Prescription intranasal option that avoids injections but depends on intact mucosal absorption and is less suitable for severe malabsorption.
- Cyanoject (injectable cyanocobalamin) — Brand injectable cyanocobalamin similar in indication and dose range; choice between brands is clinical and formulary-driven.
- Generic cyanocobalamin IM — Therapeutically equivalent injectable generics that provide the same IM route and dose ranges; selection often depends on availability.
- Over-the-counter oral cyanocobalamin supplements — Non-prescription route appropriate for patients with normal absorption; delivers microgram doses rather than the 500–1,000 µg IM bolus.
Who Should Buy This & Who Should Skip It
Buy it if: Clinicians and patients should choose high-dose cyanocobalamin IM if there is documented vitamin B12 deficiency due to pernicious anemia, gastrointestinal malabsorption, surgical resection, or if rapid repletion is required and oral absorption is unreliable. It is also appropriate for patients unable to maintain B12 status through diet or OTC supplements.
Skip it if: Avoid this product in patients with known Leber's hereditary optic neuropathy or confirmed cobalt allergy; these patients need alternative approaches. Patients with intact oral absorption or who prefer noninvasive routes may be better served by oral supplements or the intranasal prescription option.
Search Purchase Options
Use these links to search for High-dose cyanocobalamin IM (500–1,000 µg) on trusted marketplaces. The links open in new tabs; if you buy through them, we may earn a commission at no extra cost to you.
* Affiliate links: you pay the same price either way.